Forest Labs's most recent trend suggests a bullish bias. One trading opportunity on Forest Labs is a Bull Put Spread using a strike $92.50 short put and a strike $87.50 long put offers a potential 11.11% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $92.50 by expiration. The full premium credit of $0.50 would be kept by the premium seller. The risk of $4.50 would be incurred if the stock dropped below the $87.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Forest Labs is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Forest Labs is bullish.
The RSI indicator is at 62.77 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Forest Labs
Milestone Payments for Adamas
Thu, 22 May 2014 20:10:05 GMT
FOREST LABORATORIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Thu, 22 May 2014 17:06:14 GMT
Actavis shares should be bought ahead of guidance, says Sterne Agee
Thu, 22 May 2014 12:44:40 GMT
Forest Laboratories, Inc. Commences Consent Solicitations to Eliminate Existing Registration Rights Obligations on Certain of its Senior Notes
Thu, 22 May 2014 12:30:00 GMT
Business Wire – Forest Laboratories, Inc. today announced that, subject to the close of the pending acquisition of Forest by Actavis plc , Actavis is off
Actavis Offers to Guarantee Certain Forest Laboratories Senior Notes in connection with Forest Consent Solicitations
Thu, 22 May 2014 12:30:00 GMT
PR Newswire – DUBLIN, May 22, 2014 /PRNewswire/ — Actavis plc (ACT) today announced that, subject to the close of its pending acquisition (the “Acquisition”) of Forest Laboratories, Inc. (FRX), it is offering to guarantee certain of Forest's outstanding debt securities in exchange for the elimination of the existing registration rights obligations with respect to those outstanding debt securities. Forest is soliciting consents (“Consents”) from holders of its securities listed in the table below (the “FRX Notes”) to eliminate Forest's existing contractual registration rights obligations (the “Proposed Amendments”) (each, a “Consent Solicitation” and, together, the “Consent Solicitations”). In exchange for the elimination of such registration rights, and subject to certain conditions and the closing of the Acquisition, Actavis is offering to issue an unconditional and irrevocable guarantee (each, an “ACT Guarantee” and, together, the “ACT Guarantees”) of each series of FRX Notes as identified in the table below:
Related Posts
Also on Market Tamer…
Follow Us on Facebook